Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
The renin-angiotensin-aldosterone system (RAAS) plays a dominant role in the pathophysiology of hypertension, diabetes mellitus, chronic kidney disease and chronic heart failure. Therefore, drugs that block key components of the RAAS such as ACE inhibitors (ACEI) and angiotensin receptor blockers (A...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2009-11-01
|
| סדרה: | Pharmaceuticals |
| נושאים: | |
| גישה מקוונת: | http://www.mdpi.com/1424-8247/2/3/118/ |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|